|
|
| | (R)-()-JWH 073 N-(3-hydroxybutyl) metabolite Basic information |
| | (R)-()-JWH 073 N-(3-hydroxybutyl) metabolite Chemical Properties |
| solubility | DMF: 30 mg/ml
DMF: PBS (pH 7.2) (1:9): 0.1 mg/ml
DMSO: 30 mg/ml
Ethanol: 0.5 mg/ml
Methanol: PBS (pH 7.2) (1:2): 0.1 mg/ml |
| | (R)-()-JWH 073 N-(3-hydroxybutyl) metabolite Usage And Synthesis |
| Description | (R)-(−)-JWH 073 N-(3-hydroxybutyl) metabolite is a purified single enantiomer of a major metabolite of JWH 073, produced by human liver microsomes in vitro and detected, as a glucuronidated form, in urine.1,2,3 The biological actions of this metabolite are unknown.WARNING This product is not for human or veterinary use. | | References | [1] ANNETTE WINTERMEYER. In vitro phase I metabolism of the synthetic cannabimimetic JWH-018[J]. Analytical and Bioanalytical Chemistry, 2010, 398 5: 2141-2153. DOI: 10.1007/s00216-010-4171-0
[2] QIANG ZHANG. Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS[J]. Analytical and Bioanalytical Chemistry, 2006, 386 5: 1345-1355. DOI: 10.1007/s00216-006-0717-6
[3] KRISHNA C. CHIMALAKONDA. Solid-Phase Extraction and Quantitative Measurement of Omega and Omega-1 Metabolites of JWH-018 and JWH-073 in Human Urine[J]. Analytical Chemistry, 2011, 83 16: 6381-6388. DOI: 10.1021/ac201377m |
| | (R)-()-JWH 073 N-(3-hydroxybutyl) metabolite Preparation Products And Raw materials |
|